Cloning variable region genes of clonal lymphoma immunoglobulin for generating patient-specific idiotype DNA vaccine.

[1]  D. Berry,et al.  Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  E. Kimby,et al.  Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Mattick,et al.  Touchdown PCR for increased specificity and sensitivity in PCR amplification , 2008, Nature Protocols.

[4]  Michel C Nussenzweig,et al.  Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. , 2008, Journal of immunological methods.

[5]  D. Mahvi,et al.  Intratumoral injection of IL-12 plasmid DNA – results of a phase I/IB clinical trial , 2007, Cancer Gene Therapy.

[6]  Robert A Kyle,et al.  Diagnosis and management of Waldenstrom's macroglobulinemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  L. Kwak,et al.  Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo. , 2004, Blood.

[8]  T. Strong,et al.  Development of a Polynucleotide Vaccine from Melanoma Antigen Recognized by T Cells-1 and Recombinant Protein from Melanoma Antigen Recognized by T Cells-1 for Melanoma Vaccine Clinical Trials , 2000, Journal of immunotherapy.

[9]  L. Kwak,et al.  Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity , 1999, Nature Biotechnology.

[10]  L. Kwak,et al.  Development of vaccine strategies for the treatment of B-cell malignancies. , 1997, Cancer investigation.